Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A tale of two drugs: Molnupiravir and Paxlovid

1 Jan 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to PARP inhibition in cancer therapy
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39920989
DOI: 10.1016/j.mrrev.2025.108533

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A tale of two drugs: Molnupiravir and PaxlovidPMID 39920989Read ↗

No compelling reason to adopt new antivirals whenever it is reasonable to wait.Semantic proximity Read ↗

Discovery and Development of Safe-in-Man Broad-Spectrum Antiviral AgentsSemantic proximity Read ↗

Effectiveness of Paxlovid - a reviewSemantic proximity Read ↗

COVID drug drives viral mutations - and now some want to halt its use.Semantic proximity Read ↗

Management of direct-acting antiviral agent failuresSemantic proximity Read ↗

Tipranavir.Semantic proximity Read ↗

Baloxavir marboxil: the new influenza drug on the marketSemantic proximity Read ↗

New drugs.Semantic proximity Read ↗

Resistance: Crizotinib makes a comeback.Semantic proximity Read ↗

Current status of small molecule drug development for Ebola virus and other filovirusesSemantic proximity Read ↗

Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replicationSemantic proximity Read ↗

Revakinagene Taroretcel: First ApprovalSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.